Harvard Bioscience (HBIO)
(Delayed Data from NSDQ)
$3.62 USD
+0.06 (1.69%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.63 +0.01 (0.28%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Brokerage Reports
0 items in cart
Harvard Bioscience, Inc. [HBIO]
Reports for Purchase
Showing records 1 - 20 ( 50 total )
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
3Q23 - Strong Execution Outshines Macro Impacted Results
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Life Science Earnings Recap: Three Groups of Opportunity Ahead, One Area of Risk (China)
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
2Q23 - Setup Improving with Margins, Less Debt, New Products
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
1Q23 - Cleanest Quarter Since CEO Arrival
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Life Science Technology - Biologic Transformation Continues - 2023 Outlook
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
3Q Shortfall, Mgmt. Maintaining Turnaround Goals
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
2Q Headwinds, but Focused on the Turnaround
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Macro Negatives but Sales Integration More Interesting
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department